Major Pharma Trials Deliver Positive Results; EchoStar Navigates FCC Scrutiny with $23 Billion AT&T Deal; EU Considers China Sanctions
Key Takeaways Eli Lilly (LLY) announced positive topline results from its Phase 3 BRUIN CLL-314 trial for Jaypirca (pirtobrutinib), demonstrating […]
